Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00172094 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches
A Phase 2 study, sponsored by Shire.
- Completed
- Registry status
- Phase 2
- Development phase
- 189
- Enrollment target
NCT00172094 is a Phase 2 study that has completed, run by Shire. The registered enrollment target is 189 participants.
The verdict
NCT00172094, a Phase 2 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 189 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate the effectiveness and safety of a single oral dose of NPS 1776 in the acute treatment of migraine pain and associated symptoms.
Interventions
- DRUG PLACEBO
- DRUG NPS 1776 (800 mg)
- DRUG NPS 1776 (400 mg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2003-12-31 |
| Est. Completion | 2004-07-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00172094
The ClinicalTrials.gov registry entry for NCT00172094 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 189 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PLACEBO is the first listed.
NCT00172094 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00172094 about?
NCT00172094 is a clinical study titled "Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches". The purpose of this study was to evaluate the effectiveness and safety of a single oral dose of NPS 1776 in the acute treatment of migraine pain and associated symptoms.
What is the current status of trial NCT00172094?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 189 participants. The study started on 2003-12-31. Estimated completion is 2004-07-31.
What interventions are being tested in trial NCT00172094?
The interventions under investigation include: PLACEBO (DRUG), NPS 1776 (800 mg) (DRUG), NPS 1776 (400 mg) (DRUG).
Who is sponsoring clinical trial NCT00172094?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.